US Stock MarketDetailed Quotes

XBIT XBiotech

Watchlist
  • 4.560
  • +0.060+1.33%
Close Dec 24 13:00 ET
  • 4.560
  • 0.0000.00%
Post 17:01 ET
139.00MMarket Cap-4.22P/E (TTM)

About XBiotech Company

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.

Company Profile

SymbolXBIT
Company NameXBiotech
Listing DateApr 15, 2015
Issue Price19.00
Founded2005
CEOMr. John Simard
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
Address5217 Winnebago Lane
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78744
Phone1-512-386-2900

Company Executives

  • Name
  • Position
  • Salary
  • John Simard
  • Chairman of the Board, President and Chief Executive Officer
  • 5.56M
  • Sushma Shivaswamy
  • Chief Scientific Officer
  • 720.50K
  • Angela Hu
  • Director of Finance, Principal Financial Officer and Principal Accounting Officer
  • 279.29K
  • Dr. Peter Libby, M.D.
  • Independent Director
  • 163.94K
  • W. Thorpe Mckenzie
  • Independent Director
  • 190.94K
  • Jan-Paul Waldin, Esq.
  • Lead Independent Director
  • 196.94K
  • Donald H. MacAdam
  • Independent Director
  • 187.94K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.